Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase

Leuk Lymphoma. 2023 Nov-Dec;64(11):1880-1883. doi: 10.1080/10428194.2023.2239406. Epub 2023 Jul 30.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Asparaginase / adverse effects
  • Child
  • Female
  • Humans
  • Polyethylene Glycols / adverse effects
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Pregnancy

Substances

  • pegaspargase
  • Asparaginase
  • Polyethylene Glycols
  • Antineoplastic Agents